Your browser doesn't support javascript.
loading
Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases?
Frick, Sven; Müller, Daniel; Kullak-Ublick, Gerd A; Jetter, Alexander.
Afiliación
  • Frick S; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Rämistrasse 100, CH-8091, Zürich, Switzerland.
  • Müller D; Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Rämistrasse 100, CH-8091, Zürich, Switzerland.
  • Jetter A; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Rämistrasse 100, CH-8091, Zürich, Switzerland. alexander.jetter@usz.ch.
Eur J Clin Pharmacol ; 75(3): 335-342, 2019 Mar.
Article en En | MEDLINE | ID: mdl-30610277
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azatioprina / Enfermedades Inflamatorias del Intestino / Modelos Estadísticos / Monitoreo de Drogas / Mercaptopurina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Eur J Clin Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azatioprina / Enfermedades Inflamatorias del Intestino / Modelos Estadísticos / Monitoreo de Drogas / Mercaptopurina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Eur J Clin Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Suiza